WPD Pharmaceuticals Inc. (CSE: WBIO)
Canada
· Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Dec 19, 2024, 9:30 AM EST
WPD Pharmaceuticals Statistics
Total Valuation
WPD Pharmaceuticals has a market cap or net worth of CAD 579,936. The enterprise value is 961,475.
Market Cap | 579,936 |
Enterprise Value | 961,475 |
Important Dates
The last earnings date was Friday, November 29, 2024.
Earnings Date | Nov 29, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
WPD Pharmaceuticals has 115.99 million shares outstanding. The number of shares has increased by 0.57% in one year.
Current Share Class | n/a |
Shares Outstanding | 115.99M |
Shares Change (YoY) | +0.57% |
Shares Change (QoQ) | +1.65% |
Owned by Insiders (%) | 22.38% |
Owned by Institutions (%) | n/a |
Float | 77.94M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -143.38 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.10
Current Ratio | 0.10 |
Quick Ratio | 0.10 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.93 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -71.58% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -419 |
Employee Count | 16 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.89% in the last 52 weeks. The beta is 0.76, so WPD Pharmaceuticals's price volatility has been lower than the market average.
Beta (5Y) | 0.76 |
52-Week Price Change | -88.89% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.02 |
Relative Strength Index (RSI) | 25.75 |
Average Volume (20 Days) | 30,168 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -290,036 |
Pretax Income | -6,706 |
Net Income | -6,706 |
EBITDA | -285,095 |
EBIT | -290,036 |
Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 9,339 in cash and 390,880 in debt, giving a net cash position of -381,541 or -0.00 per share.
Cash & Cash Equivalents | 9,339 |
Total Debt | 390,880 |
Net Cash | -381,541 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -622,289 |
Book Value Per Share | -0.01 |
Working Capital | -487,443 |
Cash Flow
Operating Cash Flow | -171,987 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
WPD Pharmaceuticals does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.57% |
Shareholder Yield | -0.57% |
Earnings Yield | -1.16% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |